Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lou, Jinxing
BZE2209-A-01, NCT06248697: Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors	Recruiting	1	16	RoW	αPD1/CTLA4-MSLN-CAR T cells	Shanghai Cell Therapy Group Co.,Ltd	Solid Tumor	07/26	12/26
NCT06249256: An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells	Recruiting	1	12	RoW	Fast CAR T cells	Shanghai Cell Therapy Group Co.,Ltd	Solid Tumor	06/26	12/26
NCT06327997: An Exploratory Study by Fast CAR T Cells	Recruiting	1	20	RoW	Fast CAR T cells	Shanghai Cell Therapy Group Co.,Ltd	Solid Tumor	03/27	12/27
NCT06446128: A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)	Active, not recruiting	1	20	RoW	CD19/CD20/BCMA CAR T cells	Shanghai Cell Therapy Group Co.,Ltd	Non-Hodgkin Lymphoma, B-cell	12/24	07/25
NCT06036355: The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD)	Not yet recruiting	1	20	RoW	Oral NMN combined with DC cell vaccine	Shanghai Cell Therapy Group Co.,Ltd	Postoperative Prevention of Tumor	04/24	12/24